Tribune News Network
Doha
In its May/June 2024 issue, the Personalised Medicine Coalition (PMC), in its monthly landscape analysis, highlighted Qatar’s continuous efforts to advance personalised medicine.
Building on this recognition, Qatar is making significant strides in its ambitious plan to integrate personalised medicine into its national healthcare strategy, aiming to reinforce economic development and improve the quality of life for its population.
In a recent briefing to PMC, Hamad Medical Corporation (HMC) officials emphasised personalised medicine’s critical role in the Qatar National Vision 2030.
The Personalised Medicine Coalition (PMC) is a crucial organisation that advocates for promoting and advancing personalised medicine. It unites healthcare providers, researchers, patient groups and industry leaders to drive innovation, influence policies and educate the public, enhancing patient outcomes through tailored treatments.
Personalised medicine, or precision medicine, is a medical approach that tailors healthcare to individual patients based on their genetic makeup, lifestyle and environment. Considering these unique factors, it aims to create more effective and precise treatment plans, improving outcomes and reducing adverse effects.
"Personalised Medicine is a central component of our plan to sustain economic development and provide a high standard of living for our people,” said Dr Salha Bujassoum Al Bader, director of the Centre for Clinical Precision Medicine and Genomics, chairperson of Medical Oncology and Palliative Care and a leading figure at HMC. "By embracing this paradigm shift, we are committed to accomplish profound changes across all patient populations and disease states.”
Since launching its National Vision 2030, Qatar has shown a solid commitment to personalised medicine. This dedication triumphed with the establishment of the Centre for Clinical Precision Medicine and Genomics at HMC this year, Qatar’s leading provider of specialised healthcare services. This centre is set to become a cornerstone in Qatar’s healthcare infrastructure, driving forward the nation’s goals in personalised medicine.
HMC is proud to announce that its Centre for Clinical Precision Medicine and Genomics was featured in the latest issue of Personalised Medicine Today magazine. This recognition highlights the centre’s work and commitment to advancing personalised healthcare and improving the global positioning of Qatar in precision medicine.
The magazine emphasised the centre’s innovative approaches to optimal patient care, showcasing its cutting-edge research, state-of-the-art technology and dedicated team of experts. The article underscores how Qatar has made personalised medicine a central component of its plans to grow the economy and enhance the lives of its people.
"We are honoured to be recognised by Personalised Medicine Today,” said Dr Salha Bujassoum Al Bader. "This feature underlines our dedication to providing personalised management plans, research, education and advancing advocacy by utilizing cutting-edge technology and clinical uptake initiatives that ensure tests and treatments make individualised medicine possible and reach patients in need.”
Dr Bujassoum highlighted the transformative potential of personalised medicine during her briefing, stating, "Within Qatar, there is a firm belief that the adoption of precision medicine initiatives will translate into enhanced health outcomes for all citizens. Our efforts are geared towards creating a healthcare system that is proactive, predictive, and precise, ensuring that every individual receives the right treatment at the right time.”
Qatar’s commitment to personalised medicine aims to elevate the standard of healthcare within the country and contribute significantly to global research clinical care, medical education and innovation. The continued investment and development in this field reflect Qatar’s dedication to fostering a healthier future for its citizens and enhancing its international standing in medical excellence.